THE COST-EFFECTIVENESS OF ROFLUMILAST FOR COPD IN SWEDEN

被引：0

作者：

Engstrom, A. ^{[1
]}

机构：

[1] NYCOMED AS, Stockholm, Sweden

来源：

VALUE IN HEALTH | 2011年 / 14卷 / 07期

关键词：

D O I：

10.1016/j.jval.2011.08.1425

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A494 / A494

页数：1

共 50 条

[1] THE COST-EFFECTIVENESS OF ROFLUMILAST IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTING
Kotchie, R.
Samyshkin, Y.
Zammit, D. C.
Humphreys, S.
Jameson, K.
[J]. VALUE IN HEALTH, 2011, 14 (03) : A140 - A140
[2] Roflumilast as add-on therapy to conventional inhalers in COPD: a cost-effectiveness analysis
Antoniu, Sabina A.
[J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (04) : 315 - 317
[3] COST-EFFECTIVENESS OF ROFLUMILAST (DAXAS®) IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
Lindner, L.
Camins de Valdenebro, L.
Aparicio Martinez, J.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
[4] Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
Samyshkin, Yevgeniy
Schlunegger, Michael
Haefliger, Susan
Ledderhose, Sabine
Radford, Matthew
[J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 79 - 87
[5] COST-EFFECTIVENESS OF ROFLUMILAST IN COMBINATION WITH BRONCHODILATOR THERAPIES IN PATIENTS WITH SEVERE AND VERY SEVERE COPD IN SWITZERLAND
Samyshkin, Y.
Radford, M.
Schlunegger, M.
Gooss, A.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A494 - A494
[6] Cost-effectiveness of Roflumilast in the UK: A 1-year study in patients with severe to very severe COPD
Van Nooten, F.
Rutten-Van Molken, M.
Lindemann, M.
Sandtmann, R.
[J]. VALUE IN HEALTH, 2006, 9 (06) : A260 - A261
[7] Cost-effectiveness of infliximab (Remicade) in Sweden
Kobelt, G
Jonsson, L
Lindquist, E
Eberhardt, K
[J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S158 - S158
[8] The cost-effectiveness of inhaled insulin in Sweden
Neovius, M.
Pruz, C.
[J]. VALUE IN HEALTH, 2006, 9 (06) : A231 - A231
[9] The cost-effectiveness of lifesaving interventions in Sweden
Ramsberg, JAL
Sjoberg, L
[J]. RISK ANALYSIS, 1997, 17 (04) : 467 - 478
[10] THE COST-EFFECTIVENESS OF HYPERTENSION TREATMENT IN SWEDEN
JOHANNESSON, M
[J]. PHARMACOECONOMICS, 1995, 7 (03) : 242 - 250

← 1 2 3 4 5 →